Comparison of forward- and back-projection in vivo EPID dosimetry for VMAT treatment of the prostate

被引:31
作者
Bedford, James L. [1 ]
Hanson, Ian M.
Hansen, Vibeke N.
机构
[1] Inst Canc Res, Joint Dept Phys, Sutton SM2 5PT, Surrey, England
关键词
portal dosimetry; EPID; VMAT; treatment plan; MODULATED ARC THERAPY; DOSE VERIFICATION; PORTAL DOSIMETRY; STATISTICS NOTES; RADIOTHERAPY; IMRT; IMPLEMENTATION; OPTIMIZATION; IMAGES; MODE;
D O I
10.1088/1361-6560/aa9c60
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In the forward-projection method of portal dosimetry for volumetric modulated arc therapy (VMAT), the integrated signal at the electronic portal imaging device (EPID) is predicted at the time of treatment planning, against which the measured integrated image is compared. In the back-projection method, the measured signal at each gantry angle is back-projected through the patient CT scan to give a measure of total dose to the patient. This study aims to investigate the practical agreement between the two types of EPID dosimetry for prostate radiotherapy. The AutoBeam treatment planning system produced VMAT plans together with corresponding predicted portal images, and a total of 46 sets of gantry-resolved portal images were acquired in 13 patients using an iViewGT portal imager. For the forward-projection method, each acquisition of gantry-resolved images was combined into a single integrated image and compared with the predicted image. For the back-projection method, iViewDose was used to calculate the dose distribution in the patient for comparison with the planned dose. A gamma index for 3% and 3 mm was used for both methods. The results were investigated by delivering the same plans to a phantom and repeating some of the deliveries with deliberately introduced errors. The strongest agreement between forward-and back-projection methods is seen in the isocentric intensity/dose difference, with moderate agreement in the mean gamma. The strongest correlation is observed within a given patient, with less correlation between patients, the latter representing the accuracy of prediction of the two methods. The error study shows that each of the two methods has its own distinct sensitivity to errors, but that overall the response is similar. The forward-and back-projection EPID dosimetry methods show moderate agreement in this series of prostate VMAT patients, indicating that both methods can contribute to the verification of dose delivered to the patient.
引用
收藏
页数:16
相关论文
共 52 条
  • [31] Replacing pretreatment verification with in vivo EPID dosimetry for prostate IMRT
    McDermott, Leah N.
    Wendling, Markus
    Sonke, Jan-Jakob
    van Herk, Marcel
    Mijnheer, Ben J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (05): : 1568 - 1577
  • [32] Dose-response and ghosting effects of an amorphous silicon electronic portal imaging device
    McDermott, LN
    Louwe, RJW
    Sonke, JJ
    van Herk, MB
    Mijnheer, BJ
    [J]. MEDICAL PHYSICS, 2004, 31 (02) : 285 - 295
  • [33] In vivo dosimetry in external beam radiotherapy
    Mijnheer, Ben
    Beddar, Sam
    Izewska, Joanna
    Reft, Chester
    [J]. MEDICAL PHYSICS, 2013, 40 (07)
  • [34] A comparison of electronic portal dosimetry verification methods for use in stereotactic radiotherapy
    Millin, Anthony E.
    Windle, Rebecca S.
    Lewis, D. Geraint
    [J]. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2016, 32 (01): : 188 - 196
  • [35] Routine individualised patient dosimetry using electronic portal imaging devices
    Nijsten, Sebastiaan M. J. J. G.
    Mijnheer, Ben J.
    Dekker, Andre L. A. J.
    Lambin, Philippe
    Minken, Andre W. H.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2007, 83 (01) : 65 - 75
  • [36] Time-Resolved Versus Integrated Transit Planar Dosimetry for Volumetric Modulated Arc Therapy: Patient-Specific Dose Differences During Treatment, a Proof of Principle
    Persoon, L. C. G. G.
    Podesta, M.
    Nijsten, S. M. J. J. G.
    Troost, E. G. C.
    Verhaegen, F.
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2016, 15 (06) : NP79 - NP87
  • [37] Is integrated transit planar portal dosimetry able to detect geometric changes in lung cancer patients treated with volumetric modulated arc therapy?
    Persoon, Lucas C. G. G.
    Podesta, Mark
    Hoffmann, Lone
    Sanizadeh, Abir
    Schyns, Lotte E. J. R.
    de Ruiter, Ben-Max
    Nijsten, Sebastiaan M. J. J. G.
    Muren, Ludvig P.
    Troost, Esther G. C.
    Verhaegen, Frank
    [J]. ACTA ONCOLOGICA, 2015, 54 (09) : 1501 - 1507
  • [38] Clinical Experience and Evaluation of Patient Treatment Verification With a Transit Dosimeter
    Ricketts, Kate
    Navarro, Clara
    Lane, Katherine
    Blowfield, Claire
    Cotten, Gary
    Tomala, Dee
    Lord, Christine
    Jones, Joanne
    Adeyemi, Abiodun
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (05): : 1513 - 1519
  • [39] Time-resolved versus time-integrated portal dosimetry: the role of an object's position with respect to the isocenter in volumetric modulated arc therapy
    Schyns, Lotte E. J. R.
    Persoon, Lucas C. G. G.
    Podesta, Mark
    van Elmpt, Wouter J. C.
    Verhaegen, Frank
    [J]. PHYSICS IN MEDICINE AND BIOLOGY, 2016, 61 (10) : 3969 - 3984
  • [40] EPID in vivo dosimetry in RapidArc technique
    Slosarek, Krzysztof
    Szlag, Marta
    Bekman, Barbara
    Grzadziel, Aleksandra
    [J]. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2010, 15 (01) : 8 - 14